James Healy Cin Cor Pharma, Inc. (CINC) insider trading activity

CINC Quotes by TradingView

James Healy is Director of CinCor Pharma, Inc.. Currently has a direct ownership of 0 shares of CINC, which is worth approximately $0. The most recent transaction as insider was on Feb 24, 2023, when has been sold 19,608 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

JAMES HEALY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 24 2023
SELL
Sale (or disposition) back to the issuer
-
19,608 Reduced 100.0%
0 Common Stock
Feb 24 2023
SELL
Disposition due to a tender of shares in a change of control transaction
-
9,803 Reduced 33.33%
19,608 Common Stock
Aug 05 2022
BUY
Exercise of conversion of derivative security
$399,990 $13.6 p/Share
29,411 Added 50.0%
29,411 Common Stock

Also insider at

HGEN
HUMANIGEN, INC Healthcare
Director
CHRS
Coherus BioSciences, Inc. Healthcare
Director
BOLT
Bolt Biotherapeutics, Inc. Healthcare
NTRA
Natera, Inc. Healthcare
YMAB
Y-mAbs Therapeutics, Inc. Healthcare
Director
KRTX
Karuna Therapeutics, Inc. Healthcare
AVBP
ArriVent Biopharma, Inc.
Director
RAPP
Rapport Therapeutics, Inc.
Director
BIOA
BioAge Labs, Inc.
JH

James Healy

Director
Menlo Park, CA

Track Institutional and Insider Activities on CINC

Follow CinCor Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CINC shares.

Notify only if

Insider Trading

Get notified when an Cin Cor Pharma, Inc. insider buys or sells CINC shares.

Notify only if

News

Receive news related to CinCor Pharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CINC